Edition:
United States

Idera Pharmaceuticals Inc (IDRA.OQ)

IDRA.OQ on NASDAQ Stock Exchange Capital Market

2.56USD
30 Sep 2016
Change (% chg)

$0.25 (+10.82%)
Prev Close
$2.31
Open
$2.30
Day's High
$2.69
Day's Low
$2.23
Volume
805,454
Avg. Vol
113,476
52-wk High
$4.42
52-wk Low
$1.20

Select another date:

Tue, Sep 27 2016

BRIEF-Idera Pharmaceuticals announced new pre-clinical data on mechanism of action supporting selective targeting of single point mutations

* Based on specificity in targeting RNA data indicates that 3GA could be used to treat diseases that require allele-specificity

BRIEF-Idera Pharmaceuticals reports data from phase 1 trial of Intra-tumoral IMO-2125

* Idera Pharmaceuticals reports promising data from ongoing phase 1 dose escalation in clinical trial of intra-tumoral IMO-2125 in combination with Ipilimumab in patients with PD-1 refractory metastatic melanoma

BRIEF-Idera Pharmaceuticals Q2 loss per share $0.11

* Idera Pharmaceuticals reports second quarter 2016 financial results and provides corporate update

BRIEF-Idera Pharmaceuticals reports Q1 loss per share $0.11

* Idera pharmaceuticals reports first quarter 2016 financial results and provides corporate update

Select another date: